(Alliance News) - Partners Group Private Equity Ltd on Tuesday said its investment manager, Partners Group Holding AG, has agreed to exit its existing stake in PCI Pharma Services and reinvest as a ...

Mubadala’s investment is part of a strategic transaction co-led by Bain Capital and existing lead investor Kohlberg ...

Mubadala Investment Company, the Abu Dhabi-based sovereign wealth fund managing a global portfolio, is making a significant reinvestment in PCI Pharma Services (PCI).

Dubai: The Abu Dhabi investment firm Mubadala is putting in more funds into US-based PCI Pharma services, a leading player in ...

Crypto Assets Rally Ahead of Possible U.S. Legislation Crypto is continuing its bull run at the start of what has been dubbed "Crypto Week" in Washington, where the House of Representatives will ...

Business & Finance ...

Bain and Kohlberg are leading an investment round in PCI Pharma Services, valuing it at $10 billion, as AI accelerates drug ...

Education publisher McGraw Hill and consumer-intelligence provider NIQ Global Intelligence have unveiled terms of planned initial public offerings that could give each of the private equity-backed ...

A Philadelphia-based pharmaceutical services company has just received a massive investment from two major private equity firms, reportedly catapulting its valuation to $10 billion.

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its geographic reach.

PCI Pharma Services has received a strategic investment co-led by Bain Capital and existing lead investor Kohlberg, and ...

PCI Pharma Services, a Philadelphia-based biotherapy-focused contract development and manufacturing organization, has secured an investment co-led by Bain Capital and existing backer Kohlberg.